Hill, M;
Lewis, C;
Chitty, LS;
(2016)
Stakeholder attitudes and needs regarding cell-free fetal DNA testing.
Current Opinion in Obstetrics and Gynecology
, 28
(2)
pp. 125-131.
10.1097/GCO.0000000000000251.
Preview |
Text
Hill_Stakeholder%20attitudes%20and%20needs%20regarding%20cell-free%20fetal%20DNA%20testing%20130317.pdf - Accepted Version Download (467kB) | Preview |
Abstract
PURPOSE OF REVIEW: To explore stakeholder views on cell-free DNA testing and highlight findings important for successful implementation and the provision of best practice in counseling. RECENT FINDINGS: Noninvasive tests based on the analysis of cell-free fetal DNA are now widely available in clinical practice and applications are expanding rapidly. It is essential that stakeholder views are considered in order to identify and address any ethical and social issues. We provide an overview of stakeholder viewpoints and then focus on the key issues of informed decision making, test uptake, service delivery and information sources. SUMMARY: Stakeholders are positive about the introduction of cell-free fetal DNA testing into clinical practice. They describe both practical and psychological benefits arising from tests that are safe and can potentially be performed earlier in pregnancy. Key concerns, which include the potential for these tests to have a negative impact on informed decision making and increased societal pressure to have testing, can be addressed through careful parent-directed counseling. As applications for these tests expand it is increasingly important to develop innovative approaches to facilitate good understanding for parents who are offered noninvasive prenatal testing.
Type: | Article |
---|---|
Title: | Stakeholder attitudes and needs regarding cell-free fetal DNA testing |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1097/GCO.0000000000000251 |
Publisher version: | http://dx.doi.org/10.1097/GCO.0000000000000251 |
Language: | English |
Additional information: | Copyright © 2017 Wolters Kluwer Health, Inc. This is the accepted manuscript version of this article published in Current Opinion in Obstetrics and Gynecology; the final published version of record can be found at http://dx.doi.org/10.1097/GCO.0000000000000251. |
Keywords: | Science & Technology, Life Sciences & Biomedicine, Obstetrics & Gynecology, Cell-Free Fetal Dna, Counseling, Noninvasive Prenatal Testing And Diagnosis, Stakeholder Viewpoints, Noninvasive Prenatal-Diagnosis, Discrete-Choice Experiment, Single-Gene Disorders, Pregnant-Women, Down-Syndrome, Health-Professionals, Informed Choice, Likely Uptake, Aneuploidy, Preferences |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Genetics and Genomic Medicine Dept UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Population, Policy and Practice Dept |
URI: | https://discovery.ucl.ac.uk/id/eprint/1479588 |
Archive Staff Only
View Item |